AirWare Labs Strengthens Leadership Team With New Director of Product Development

AirWare Labs Strengthens Leadership Team With New Director of Product 
Health Technology Solutions Company Rounds Out Management Team With
Veteran Product Design and Development Executive; Elevates President
and Chief Operating Officer 
SCOTTSDALE, AZ -- (Marketwired) -- 04/29/14 --  AirWare Labs Corp.
(OTCQB: AIRW) today announced the addition of Mr. Dan Pool to its
executive management team and the appointment of Dr. Lorrie
Henderson, Ph.D., MBA to President and Chief Operating Officer.  
As Director of Product Development, Pool will oversee product design
and development for the AIR(R) line of nasal dilators. Pool's
impressive career spans over 30 years in the field of product design
and development. He built his first company, PC MFG, up to
$20,000,000 in annual sales and 200 employees over 10 years and sold
it along with patents in 1992 in the high seven figure range to 3M
Pool has since sold nearly a dozen inventions to a variety of
companies and gained vast experience securing the intellectual
property rights for a myriad of products. In 2005, he developed a
series of patents for CNS for nasal dilation products, which
protected their Breathe Right Nasal Strips. Pool has licensed and
developed products for Stanley Works, USG, DAP, 3M Company,
Saint-Gobaine, and ShurTech Brands, among others. His unique and
methodical approach to developing products is fostered by his belief
that everything in everyday life has room for improvement and
"Dan Pool's accomplishments in product design and innovation,
combined with his expertise in patents and intellectual property
rights, are tremendous assets to AirWare and our AIR(R) line," said
Jeffrey Rassas, CEO of AirWare Labs. "We are excited to have Dan join
us in our mission to improve lives through better breathing." 
Dr. Henderson will continue in his new role as President and COO to
further the business strategy and increase brand awareness,
profitability and shareholder value globally. Dr. Henderson brings
over 25 years of leadership experience in the field of
Healthcare/Behavioral Health. He earned his bachelor's degree from
Florida Atlantic University, his master's degree from Florida
International University, a Ph.D. from Barry University in Florida
and an MBA, summa cum laude, from Jones International University. 
AirWare Labs recently announced production on a branded video
featuring TV and movie personalities Vincent Kartheiser (of AMC's
drama Mad Men) and Adam Herschman. The company also announced plans
for a sales and manufacturing expansion into China and a licensing
agreement with Breathe Active, LLC earlier this year. AIR(TM) ALLERGY
was selected as a 2014 Visionary Award Finalist for the VISION(R)
Consumer Products Conference in Dallas, and in 2013 AirWare Labs
announced a national rollout into 7,500 Walgreen's stores. 
About AirWare Labs Corporation: 
AirWare Labs Corp. [publicly traded as (OTCQB: AIRW)] provides
patented and innovative technology solutions for consumer products
that promote better health through breathing and enhanced wellbeing.
AirWare Labs' products are marketed under the brand name of AIR(R).
AIR(R) products utilize an FDA approved medical grade silicone,
molded as an intranasal Air Breathe dilator, to act as the delivery
system. This AIR(R) microstructure enhances normal nasal airflow with
every breath -- clinically proven to deliver up to 40% more oxygen.  
Some AIR(R) products are infused with essential oils with unique
healing properties including antibacterial and therapeutic defense
against airborne allergens, viruses and bacteria. AIR(R) Allergy and
Travel products provide additional defense in the form of an
integrated filter media from 3M to remove microscopic particles that
carry viruses, allergens and bacteria. Other AIR(R) specialty
products help provide and performance enhancements and relief from
congestion, insomnia, headaches, nausea, and snoring. For more
product information, please visit: or
company information visit: 
Forward-Looking Statement: The statements in this press release
regarding any implied or perceived benefits from the release by
AirWare Labs Corp. of its AIR ALLERGY(TM) product are forward-looking
statements. Such statements involve risks and uncertainties,
including, but not limited to, risks and effects of legal and
administrative proceedings and governmental regulation, especially in
a foreign country, future financial and operational results,
competition, general economic conditions, and the ability to manage
and continue growth.  
Should one or more of these risks or uncertainties materialize, or
should underlying assumptions prove incorrect, actual outcomes may
vary materially from those indicated. Important factors that could
cause actual results to differ materially from the forward-looking
statements we make in this news release include the introduction of
new technology, market conditions and those set forth in reports or
documents we file from time to time with the SEC. We undertake no
obligation to revise or update such statements to reflect current
events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events. 
Media Contact: 
Jennifer Breitegan 
Investor Relations:
Keith Pinder
Acorn Management
Press spacebar to pause and continue. Press esc to stop.